Merck to cut 500 US jobs

Citing a need to shift resources to different research and development projects, Merck said it will eliminate 500 U.S. jobs by Jan. 3, according to EndPoints News.

Advertisement

Most of the affected roles include sales employees and commercial teams at its Pennsylvania headquarters. It also includes job cuts in New Jersey and employees working remotely from across the U.S. 

“This is not a new restructuring effort; these changes are part of ongoing companywide efforts to sharpen Merck’s focus on innovative research and development that addresses significant unmet medical needs and on our best opportunities for growth,” the drugmaker told the pharmaceutical industry news website. 

Affected employees can apply for open jobs within Merck, or they will be offered a separation package. 

The drugmaker said it plans to add jobs in oncology and other growth areas. 

More articles on pharmacy:
Novant Health to open health clinics inside Walgreens
GlaxoSmithKline recalls prescription heartburn drug globally
BIO CEO to step down at the end of 2020

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.